NCT00491257View on ClinicalTrials.gov

A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
InfluenzaOrthomyxoviridae Infections
Interventions
BIOLOGICAL

Inactivated influenza vaccine (split virion) NH 2007-2008 formulation

0.5 mL, Intramuscular

Trial Locations (2)

Unknown

Edinburgh

London

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00491257 - A Study of the Immunogenicity and Safety of the 2007-2008 Influenza Vaccine | Biotech Hunter | Biotech Hunter